Page 5 - 03475v10 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AngioDynamics (NASDAQ:ANGO – Free Report) had its price target upped by Canaccord Genuity Group from $18.00 to $20.00 in a research note published on Thursday, Benzinga reports. They currently have a buy rating on the medical instruments supplier’s stock. Other equities research analysts have also recently issued reports about the company. StockNews.com upgraded AngioDynamics from […]

AngioDynamics (NASDAQ:ANGO – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided EPS guidance of -$0.34–$0.28 for the period, compared to the consensus EPS estimate of -$0.02. The company issued revenue guidance of $328.00 million-$333.00 million, compared to the consensus revenue estimate of $353.62 million. Analyst Ratings Changes A number […]

AngioDynamics (NASDAQ:ANGO – Get Free Report) posted its quarterly earnings results on Wednesday. The medical instruments supplier reported $0.02 EPS for the quarter, meeting analysts’ consensus estimates of $0.02, MarketWatch Earnings reports. The business had revenue of $91.10 million for the quarter, compared to analysts’ expectations of $90.73 million. AngioDynamics had a negative return on […]

AngioDynamics (NASDAQ:ANGO – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share guidance of ($0.34)-($0.28) for the period, compared to the consensus earnings per share estimate of ($0.03). The company issued revenue guidance of $328-333 million, compared to the consensus revenue estimate of $353.75 million. Analyst Ratings Changes […]

StockNews.com assumed coverage on shares of AngioDynamics (NASDAQ:ANGO – Get Rating) in a research report report published on Thursday morning. The brokerage issued a hold rating on the medical instruments supplier’s stock. Separately, Raymond James cut AngioDynamics from a strong-buy rating to an outperform rating and decreased their target price for the stock from $14.00 […]